These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 6014440

  • 21. In vivo studies on the mechanism of the antifibrinolytic action of E-aminocaproic acid (EACA).
    Lukasiewicz H, Niewiarowski S.
    Thromb Diath Haemorrh; 1968 Jul 31; 19(3):584-92. PubMed ID: 4236825
    [No Abstract] [Full Text] [Related]

  • 22. Quantitative monitoring of intravascular coagulation and fibrinolysis in the lungs of rats.
    Coombey D, Tyler HM.
    Thromb Diath Haemorrh; 1972 Apr 30; 27(2):241-5. PubMed ID: 5049613
    [No Abstract] [Full Text] [Related]

  • 23. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
    Midura-Nowaczek K, Bruzgo I, Roszkowska-Jakimiec W, Worowski K.
    Acta Pol Pharm; 1994 Apr 30; 51(6):499-504. PubMed ID: 7762400
    [Abstract] [Full Text] [Related]

  • 24. [Comparative studies on the antifibrinolytic effect (in vitro and in vivo) of t-AMCHA, phenyl-t-AMCHA, trasylol].
    Moriguchi S.
    Nihon Seirigaku Zasshi; 1971 Apr 30; 33(6):355-63. PubMed ID: 5315192
    [No Abstract] [Full Text] [Related]

  • 25. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F, Klöcking HP.
    Biomed Biochim Acta; 1983 Apr 30; 42(6):725-30. PubMed ID: 6605748
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
    Thorsen S, Astrup T.
    Thromb Diath Haemorrh; 1974 Dec 31; 32(2-3):306-24. PubMed ID: 4281113
    [No Abstract] [Full Text] [Related]

  • 28. [The behavior of plasmatic fibrinogenolytic activity after activation with streptokinase and urokinase in presence of epsilon amino-caproic acid and of the parotid inhibitor of trypsin].
    Ferrauto A, Cristaldi R, Terranova R, Giuffrida G.
    Boll Soc Ital Biol Sper; 1965 Dec 31; 41(24):1486-7. PubMed ID: 5298373
    [No Abstract] [Full Text] [Related]

  • 29. [Effect of sigma-aminocaproic acid on blood coagulation and its fibrinolytic activity in vitro].
    Skipetrov VP, Bobrenko GV, Vashchenko TN, Simonova GP.
    Probl Gematol Pereliv Krovi; 1970 Jun 31; 15(6):39-42. PubMed ID: 5471517
    [No Abstract] [Full Text] [Related]

  • 30. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
    Geratz JD.
    Thromb Diath Haemorrh; 1971 Jun 30; 25(3):391-404. PubMed ID: 5314899
    [No Abstract] [Full Text] [Related]

  • 31. [Effect of fibrinolytics and antifibrinolytics on wound healing. Experimental study].
    Wilde J, Ampt HJ.
    Z Exp Chir; 1971 Jun 30; 4(4):241-7. PubMed ID: 5317395
    [No Abstract] [Full Text] [Related]

  • 32. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN, Kizim AI.
    Vopr Med Khim; 1984 Jun 30; 30(5):13-22. PubMed ID: 6084892
    [Abstract] [Full Text] [Related]

  • 33. [Pharmacological study of some inhibitors of fibrinolysis].
    Gavrilov AP.
    Farmakol Toksikol; 1967 Jun 30; 30(4):460-3. PubMed ID: 5598902
    [No Abstract] [Full Text] [Related]

  • 34. Comparative studies on inhibitors of fibrinolysis in vitro and in vivo.
    Deutsch E, Fischer M.
    Acta Haematol; 1968 Jun 30; 39(1):1-12. PubMed ID: 4968865
    [No Abstract] [Full Text] [Related]

  • 35. [Hyperfibrinolysis as the cause of so-called "spontaneous hemorrhages"].
    Perlick E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969 Jun 30; 92(1):57-63. PubMed ID: 4189373
    [No Abstract] [Full Text] [Related]

  • 36. [Trypsin inhibition by new antifibrinolytics].
    Gülzow M, Mix H, Trettin HJ.
    Hoppe Seylers Z Physiol Chem; 1967 Mar 30; 348(3):285-8. PubMed ID: 5589206
    [No Abstract] [Full Text] [Related]

  • 37. Effect of epsilon-aminocaproyl-S-benzyl-L-cysteine on the activity of plasminogen activators.
    Bruzgo I, Midura-Nowaczek K, Kaczyńska J, Krajewska D.
    Acta Pol Pharm; 2009 Mar 30; 66(1):37-40. PubMed ID: 19226966
    [Abstract] [Full Text] [Related]

  • 38. [The inhibitors of fibrinolysis: new information on antifibrinolytic agents].
    Giacomazzi G.
    Haematologica; 1968 Mar 30; 53(7):489-533. PubMed ID: 4976851
    [No Abstract] [Full Text] [Related]

  • 39. Blood coagulation and fibrinolysis.
    Heimburger N, Trobisch H.
    Angew Chem Int Ed Engl; 1971 Feb 30; 10(2):85-97. PubMed ID: 4995468
    [No Abstract] [Full Text] [Related]

  • 40. Fibrinolysis.
    Fearnley GR.
    Adv Drug Res; 1973 Feb 30; 7():107-63. PubMed ID: 4280240
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.